EUVIMEDEUVIMED entdecken
Crossref

Considering new lessons about the use of IL-6 inhibitors in arthritis

Tsutomu Takeuchi, Josef S Smolen, Ernest H Choy, Daniel Aletaha, Iain McInnes, Simon A Jones

Considerations in Medicine · 2018

DOI: 10.1136/conmed-2018-000002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Considerations in Medicine, 2018. Verfasst von Tsutomu Takeuchi und 5 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interleukin (IL)−6 represents one of several possible targets for the treatment of rheumatoid arthritis. Drugs targeting IL-6 can be divided into monoclonal antibodies against IL-6 itself and monoclonal antibodies against the IL-6 receptor. Both types of agent inhibit both classical signalling through membrane­-bound IL-6 receptor, and trans-signalling via formation of a complex between IL-6 and soluble IL-6 receptor. The IL-6 receptor blockers tocilizumab and sarilumab inhibit the low affinity binding of IL-6 to its receptor. The anti-IL-6 agents clazakizumab and vobarilizumab also block binding of IL-6 to the receptor, while olokizumab blocks the higher affinity interaction of the IL-6-receptor complex with gp130. The doses and dosing intervals of the biologics targeting different elements vary, but no major differences in efficacy or safety have yet been seen between the two approaches, although more studies are needed in this area. In addition to the different blocking actions of monoclonal antibodies, we consider therapeutic strategies including the timing of IL-6 blockade and the use of monotherapy versus the addition of methotrexate.

Zitieren

APA

Takeuchi, T., Smolen, J. S., Choy, E. H., Aletaha, D., McInnes, I., & Jones, S. A. (2018). Considering new lessons about the use of IL-6 inhibitors in arthritis. Considerations in Medicine. https://doi.org/10.1136/conmed-2018-000002

Vancouver

Takeuchi T, Smolen JS, Choy EH, Aletaha D, McInnes I, Jones SA. Considering new lessons about the use of IL-6 inhibitors in arthritis. Considerations in Medicine. 2018. doi:10.1136/conmed-2018-000002

BibTeX
@article{Takeuchi2018,
  author = {Takeuchi, Tsutomu and Smolen, Josef S and Choy, Ernest H and Aletaha, Daniel and McInnes, Iain and Jones, Simon A},
  title = {Considering new lessons about the use of IL-6 inhibitors in arthritis},
  journal = {Considerations in Medicine},
  year = {2018},
  doi = {10.1136/conmed-2018-000002}
}
Kostenlos starten →